NCT07759375Not yet recruiting
Combined Intervention Program for Non-fluent Aphasia Based on Neuroplasticity
Combining Melodic Intonation Therapy and Constraint-Induced Aphasia Therapy for the Treatment of Non-fluent Aphasia: A Neuroplasticity-based Sequential Protocol for a Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 14 Aug 2026
Brief summary (registry, in English)
Sequentially applying Melodic Intonation Therapy (MIT) during the subacute phase, followed by Constraint-Induced Aphasia Therapy (CIAT) during the chronic phase
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 48 (estimated)
- First submitted
- 31 Jul 2026
- Start date
- Jan 2027
- Primary completion date
- Jan 2029
- Lead sponsor
- Universidad de Granada
- Diseases
- Stroke
- NCT number
- NCT07759375
What you commit to
- Study type: Interventional
- Planned participants: 48
- From Jan 2027 to the primary completion date, Jan 2029
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- \-
Who the study is looking for
- Have suffered a single LH stroke, with the RH remaining entirely intact;
- Have a diagnosis of non-fluent aphasia characterized by non-fluent speech-with or without agrammatism, paraphasias, or stereotypies-anomia, and relatively preserved auditory comprehension;
- Be within 9 weeks post-stroke at the time of enrollment;
- Have no hearing, neurological, or psychiatric impairments;
- Not be taking any medication that could affect language processing
Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.